Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

January 27, 2022

New fund supports appendiceal cancer research

By Tom Wilemon
January 25, 2022

Comprehensive framework outlined for addressing early-onset colorectal cancer research

New research from Vanderbilt sets a comprehensive framework for addressing research challenges and patient needs for people under 50 with colorectal cancer.

By Tom Wilemon
January 24, 2022

Donna Atherton and Karen Pinkard are nurses who have worked together for years. The day Karen’s heart stopped at work, Donna was there to save her life.

A lot of people worked to save her life and help her recover. Thanks to them, Karen Pinkard is back at work.

By Tom Wilemon
January 19, 2022

Clinical score can guide PRRT therapy decisions for neuroendocrine tumors

A clinical score system developed by researchers at Vanderbilt-Ingram Cancer Center (VICC) has been validated that can guide peptide receptor radionuclide therapy treatment decisions.

By Tom Wilemon
January 5, 2022

Drug modifies epigenome in aggressive brain tumors: study

A folic acid-like drug changed a DNA process within brain tumors of glioblastoma patients, according to results from a phase 1 clinical trial.

By Tom Wilemon
December 24, 2021

Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate

New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death.

By Tom Wilemon
December 14, 2021

Study sets framework for precision surveillance of colorectal cancer

Vanderbilt research has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine.
By Tom Wilemon
December 13, 2021

Oral microbes and gastric cancer

Studies in three large population cohorts that include Asian, African American and European American people support a role for the oral microbiota — the collection of microbial species in the mouth — in gastric cancer development.
By Leigh MacMillan
December 9, 2021

Cell signaling targets in leukemia

Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments.
By Leigh MacMillan
December 8, 2021

New Clinician Spotlight: Kelly Hewitt

Kelly Hewitt, MD, recently joined the Division of Surgical Oncology after being recruited from St. Charles Health System in Bend, Oregon, where she served as medical director of the Breast Program.
By VUMC News and Communications
December 6, 2021

VUMC remembers patients who died over past year with special virtual memorial service

The program features speakers from different hospital departments, staff testimonials of patients at the end of their lives, a reading of loved ones’ names and a montage set to John Prine's "I Remember Everything"
By Matt Batcheldor
December 2, 2021

Thyroid cancer paper lands national recognition

By Doug Campbell
November 18, 2021

‘Multi-omics’ reveals treatment option for breast cancer subtype

By Bill Snyder